UBS AM’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-26,622
| Closed | -$103K | – | 2917 |
|
|
2019
Q3 | $103K | Buy |
26,622
+16,146
| +154% | +$62.6K | ﹤0.01% | 2660 |
|
|
2019
Q2 | $63.2K | Sell |
10,476
-4,480
| -30% | -$27K | ﹤0.01% | 2673 |
|
|
2019
Q1 | $200K | Buy |
+14,956
| New | +$200K | ﹤0.01% | 2461 |
|
|
2018
Q2 | – | Sell |
-96,858
| Closed | -$1.66M | – | 2817 |
|
|
2018
Q1 | $1.66M | Hold |
96,858
| – | – | ﹤0.01% | 1551 |
|
|
2017
Q4 | $2.12M | Sell |
96,858
-10,832
| -10% | -$237K | ﹤0.01% | 1415 |
|
|
2017
Q3 | $4.41M | Buy |
107,690
+5,600
| +5% | +$229K | ﹤0.01% | 1130 |
|
|
2017
Q2 | $3.07M | Sell |
102,090
-20,130
| -16% | -$606K | ﹤0.01% | 1205 |
|
|
2017
Q1 | $4.42M | Sell |
122,220
-34,081
| -22% | -$1.23M | ﹤0.01% | 1048 |
|
|
2016
Q4 | $7.83M | Buy |
156,301
+129,404
| +481% | +$6.49M | 0.01% | 915 |
|
|
2016
Q3 | $1.41M | Buy |
26,897
+3,176
| +13% | +$167K | ﹤0.01% | 1521 |
|
|
2016
Q2 | $981K | Buy |
23,721
+851
| +4% | +$35.2K | ﹤0.01% | 1656 |
|
|
2016
Q1 | $929K | Sell |
22,870
-5,432
| -19% | -$221K | ﹤0.01% | 1666 |
|
|
2015
Q4 | $1.17M | Buy |
+28,302
| New | +$1.17M | ﹤0.01% | 1670 |
|
|
2015
Q3 | – | Sell |
-9,600
| Closed | -$238K | – | 2711 |
|
|
2015
Q2 | $238K | Buy |
+9,600
| New | +$238K | ﹤0.01% | 2504 |
|